Systems biology approaches in asthma pharmacogenomics study.
10.4168/aard.2014.2.5.326
- Author:
Heung Woo PARK
1
Author Information
1. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea. guinea71@snu.ac.kr
- Publication Type:Review
- Keywords:
Asthma;
Pharmacogenetics;
Systems biology
- MeSH:
Asthma*;
Genes, vif;
Genome, Human;
Genome-Wide Association Study;
Humans;
Pharmacogenetics*;
Systems Biology*
- From:Allergy, Asthma & Respiratory Disease
2014;2(5):326-331
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
The response to drug treatment in asthma is a complex trait and is markedly variable even in patients with apparently similar clinical features. Pharmacogenomics is a study of variations of human genome characteristics as related to drug response. A traditional candidate-gene approach and genome-wide association studies have provided an increasing list of genes and variants that was associated with asthma medications. However, as phenotypic variations arises from a network of complex interactions among genetic and environmental factors, rather than individual genes, a multidisciplinary, system-level approach is required in order to understand the interrelationships among these factors. Systems biology that studies organisms as integrated and interacting networks of genes, proteins and biochemical reactions can contribute to this. It is likely that the combination of network modeling, functional validation, and integrative-Omics will be needed to move asthma pharmacogenomics closer to clinical relevance.
